Categories: HealthcareNews

New Obesity Medicine Association Initiative Aims to Scale High-Impact Obesity Healthcare Improvements Nationwide

Centennial, Colorado–(Newsfile Corp. – December 18, 2025) – The Obesity Medicine Association (OMA) is pleased to announce a new multi-phase Quality Improvement (QI) initiative designed to strengthen obesity care delivery across diverse outpatient clinical settings in the United States. This initiative offers OMA members a unique opportunity to enhance systems of care, streamline workflows, and implement proven, evidence-based interventions for patients with obesity.

This program is a collaboration between the Obesity Treatment Foundation (OTF), the philanthropic arm of the OMA, and Eli Lilly. OMA is also partnering with Q Synthesis LLC, a healthcare quality improvement company, to develop and implement key components of the initiative.

At the heart of the program is the Implementation into Practice Collaborative (IPC), a virtual learning collaborative that will run from February through May 2026. IPC meetings will be 60-minute, small-group, interactive working sessions held monthly and facilitated by Joseph Kim, MD, MPH, President of Q Synthesis LLC, who is certified in healthcare quality, lean six sigma, and change management. Sessions will focus on overcoming system barriers and closing the “know-do” gap by helping clinicians integrate evidence-based interventions into day-to-day practice.

OMA members participating in the IPC will also be eligible to apply for QI project grants in June 2026. Each grant, up to $150,000, will support a 12-month QI project running from July 2026 through July 2027. The OMA and OTF will oversee the grant review and selection process, while Eli Lilly will provide funding for the grants. Q Synthesis LLC will offer QI coaching and implementation support to funded projects.

All OMA members working in U.S. outpatient clinical settings are eligible to participate, and there is no cost to join the program. Space is limited. For more information or to inquire about the IPC, contact the OMA at info@obesitymedicine.org.

###

About the Obesity Medicine Association

The Obesity Medicine Association is the largest organization of clinicians dedicated to the clinical treatment of the disease of obesity. OMA provides accredited education, clinical tools, and resources to healthcare providers in obesity medicine. Visit obesitymedicine.org to learn more.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/278543

Staff

Recent Posts

Medtronic announces filing of IPO registration statement for Diabetes business, MiniMed

GALWAY, Ireland, Dec. 19, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in…

6 hours ago

Pinealage: the app that turns strangers into meditation companions — in crowdfunding phase

This app will connect people with strangers to meditate together in the real world—an invitation…

6 hours ago

IMG Saxony-Anhalt: 2026 in Sight – Saxony-Anhalt Sets the Pace for Future Industries

Despite challenging framework conditions such as high energy prices, the international introduction of tariffs, and…

6 hours ago

Kirby Medical Center Partners with Switchboard, MD to Automate Patient Communication Workflows

ATLANTA, Dec. 19, 2025 /PRNewswire/ -- Switchboard, MD is proud to announce a new enterprise partnership with…

6 hours ago

SIERRA7 RECOGNIZED AS A 2026 ELEV8 GOVCON AWARD WINNER

MCLEAN, Va., Dec. 19, 2025 /PRNewswire/ -- Sierra7, a leader in government healthcare and technology solutions,…

6 hours ago

Medome Launch Heralds the End of Medical Misdiagnoses and Lost Lives

NEW YORK, Dec. 19, 2025 /PRNewswire/ -- Medome is the first AI technology for Personal Health…

6 hours ago